Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Log In | Register FREE | Register for Free Webinar | Solution Enquiry | Subscribe
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
Webinar Webinar
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Trimurthi Ltd Stock Analysis

Small Cap
Evaluated by 59 users | BSE: 536565 | NSE: |
Trading
Read More
10YEAR X-RAY

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis P

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed 9.02%6.09%5.26%4.02%3.73%1.46%0.62%0.51%1.8%1.34%0.54%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 6.916.511.765.71.50.93.53.13.611
Y-o-Y Gr. Rt.-140.8%-29.2%-49%-3.7%-74.6%-36.3%277.4%-11.4%15.4%-71.3%-
Adjusted EPS (Rs.) 1.010.70.620.470.510.20.090.070.260.20.08-3.77
Y-o-Y Gr. Rt.--30.7%-11.4%-24.2%8.5%-60.8%-55%-22.2%271.4%-23.1%-60%-
Book Value per Share (Rs.) 11.311.6511.9913.6214.131414.1214.3114.614.8314.910.97
Adjusted Net Profit 0.70.50.40.40.40.20.10.10.20.20.1-3
Net Op. Cash Flow (Rs. Cr.) -0.6-0.6-0.4-3.50-0.42-1.11.1-0.41.2-
Debt to Cash Flow from Ops -0.39-0.26-0.21-0.021.26000000-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Trimurthi Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales -26.5%-6.7%-33.6%-71.3%
Adjusted EPS -21.4%-16.7%4.6%-60%
Book Value per Share 2.81.31.40.5
Share Price -12.1% -3% -1.7% -2.5%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) 9.246.095.243.993.71.430.620.511.81.340.54-29.15
Operating Profit Margin (%) 9.172.136.2913.8615.4347.742.725.2115.35.02-27.62-306.78
Net Profit Margin (%) 9.962.863.576.417.2411.27.531.686.774.436.28-272.65
Debt to Equity 0.030.020.010.0100000000
Working Capital Days 2971352736456202,3643,3018591,0338902,8512112
Cash Conversion Cycle 804194155711452532851537962092
Price Chart
Loading price chart...
shareholding patterns

Shareholding Pattern

Entity Percentage Holding
Promoters 66.92%
Non-Institutions 33.08%
shareholding patterns

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
shareholding patterns

FAQs

1. Is Trimurthi a good quality company?
Data is not available for this company.
2. Is current market price of Trimurthi a good price to buy it?

Trimurthi Ltd's earnings have declined by -16.7%, whereas share price has declined -3% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

3. What is Trimurthi share price return in the past 10 years ?

Trimurthi Ltd share price has declined -12.1% annually (CAGR) over the past ten years.

4. Is Trimurthi a good long term investment?

Data is not available for this company.

shareholding patterns

About Trimurthi

Trimurthi Drugs & Pharmaceuticals is an India-based company. The Company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products. The Company’s range of products include antibiotics, anti ulcer, anti inflammatory, antitussive/expectorant, cardiovascular, anti fungal, anti retroviral drugs, syrups and protein powder. The company since 1976 is built on the philosophy of commitment to quality and responsiveness.

2012 -The Company entered

Read More

Trimurthi Drugs & Pharmaceuticals is an India-based company. The Company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products. The Company’s range of products include antibiotics, anti ulcer, anti inflammatory, antitussive/expectorant, cardiovascular, anti fungal, anti retroviral drugs, syrups and protein powder. The company since 1976 is built on the philosophy of commitment to quality and responsiveness.

2012 -The Company entered into a Manufacturing Agreement with M/s. Bharat Parenterals Limited, Vadodara, Gujrat for exclusive manufacture of Company's 12 products for export. The Company entered into Distribution Agreement with Zyanya Global Pte Limited, Vietnam for selling the Company's Products in Vietnam.

Business areas of the company:

The company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products.

Divisions:

Pharma Business, Financial Services, Investment in Shares and Trading in Shares

Read Less
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback